Registration Dossier

Data platform availability banner - registered substances factsheets

Please be aware that this old REACH registration data factsheet is no longer maintained; it remains frozen as of 19th May 2023.

The new ECHA CHEM database has been released by ECHA, and it now contains all REACH registration data. There are more details on the transition of ECHA's published data to ECHA CHEM here.

Diss Factsheets

Toxicological information

Basic toxicokinetics

Currently viewing:

Administrative data

Endpoint:
basic toxicokinetics in vivo
Type of information:
experimental study
Adequacy of study:
weight of evidence
Reliability:
2 (reliable with restrictions)
Rationale for reliability incl. deficiencies:
other: Study not performed according to a guideline, but materials & methods and results are well described. Only absorption/excretion is studied.

Data source

Reference
Reference Type:
publication
Title:
Absorption of oxalic acid in rats by means of a 14C method
Author:
Bannwart, C., Hagmaier, V., Rutishauser
Year:
1979
Bibliographic source:
European Urology, Vol 5, p 276-277

Materials and methods

Objective of study:
absorption
Test guideline
Qualifier:
no guideline followed
Principles of method if other than guideline:
13 female Wistar rats received a daily dose of 0.5 mL of a 1% solution of 14C-marked sodium oxalate (specific activity 29 nCi/mL) by gavage. This concentration corresponds to 17 mg oxalic acid/kg/day, which lies between the values found for humans 1-14 mg/kg/day) and rats (46-92 mg/kg/day). Feces and urine were collected every 24 hr and the amount of 14C-oxalate was determined by liquid scintillation counting.
GLP compliance:
not specified

Test material

Constituent 1
Chemical structure
Reference substance name:
Oxalic acid
EC Number:
205-634-3
EC Name:
Oxalic acid
Cas Number:
144-62-7
Molecular formula:
C2H2O4
IUPAC Name:
oxalic acid
Specific details on test material used for the study:
Specific activity of the 14C-marked oxalate solution was 29 nCi/mL
Sodium oxalate was obtained from Merck, 14C-oxalate, H2C2O4 double brand was obtained from Amersham
Radiolabelling:
yes
Remarks:
14C

Test animals

Species:
rat
Strain:
Wistar
Sex:
female
Details on test animals or test system and environmental conditions:
TEST ANIMALS
- Weight at study initiation: 200 g
- Individual metabolism cages: yes

Administration / exposure

Route of administration:
oral: gavage
Vehicle:
not specified
Details on exposure:
PREPARATION OF DOSING SOLUTIONS:

TEST SUBSTANCE
-Specific activity of 14C-marked solution: 29 nCi/mL

VEHICLE
- Concentration in vehicle: 1% sodium oxalate solution
- Amount of vehicle (if gavage): 0.5 mL
Duration and frequency of treatment / exposure:
Animals were treated once daily, over a 7-day period
Doses / concentrations
Dose / conc.:
0.5 other: mL of a 1% sodium oxalate solution
No. of animals per sex per dose / concentration:
One dose tested, 13 animals
Control animals:
no
Positive control reference chemical:
No data
Details on study design:
No data
Details on dosing and sampling:
PHARMACOKINETIC STUDY (Absorption, distribution, excretion)
- Tissues and body fluids sampled: urine, faeces
- Time and frequency of sampling: daily (before the administration of every new dose of oxalate solution)
Statistics:
No data

Results and discussion

Toxicokinetic / pharmacokinetic studies

Details on absorption:
The distribution of 14C-oxalate in the excretion of 13 animals during a 7-day period is 25.2% in urine and 73.4% in feces. The over-all recovery is 98.6%.
Details on distribution in tissues:
No data
Details on excretion:
The distribution of 14C-oxalate in the excretion of 13 animals during a 7-day period is 25.2% in urine and 73.4% in feces. The over-all recovery is 98.6%.

Metabolite characterisation studies

Metabolites identified:
not specified

Any other information on results incl. tables

The following table is reproduced from the publication. It summarizes the distribution of 14C-oxalate between faeces and urine in 13 animals for 7 days (1 daily dose = 100%)

Animal no.

Feces, %

Urine, %

1

73.5

14.0

2

50.7

33.1

3

74.2

42.0

4

58.2

31.9

5

67.8

22.9

6

65.0

33.2

7

84.9

20.1

8

67.2

26.6

9

80.1

27.8

10

80.5

20.9

11

99.5

18.5

12

72.4

30.3

13

79.5

15.6

_

x

73.4

25.2

Total

98.6%

s

12.4

6.9

Applicant's summary and conclusion

Conclusions:
Under the conditions of the current study, the distribution of 14C-oxalate in the excretion of 13 animals during a 7-day period is 25.2% in urine and 73.4% in feces. The over-all recovery was 98.6%.
No bioaccumulation potential based on study results
Executive summary:

13 female Wistar rats received a daily dose of 0.5 mL of a 1% solution of 14C-marked sodium oxalate (specific activity 29 nCi/mL) by gavage. This concentration corresponds to 17 mg oxalic acid/kg/day, which lies between the values found for humans 1-14 mg/kg/day) and rats (46-92 mg/kg/day). Feces and urine were collected every 24 hr and the amount of 14C-oxalate was determined by liquid scintillation counting.

The distribution of 14C-oxalate in the excretion was 25.2% in urine and 73.4% in feces. The over-all recovery was 98.6%.